Suppr超能文献

信号核苷和核苷酸的核糖环构象调查。

Survey of ribose ring pucker of signaling nucleosides and nucleotides.

作者信息

Salmaso Veronica, Jacobson Kenneth A

机构信息

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

出版信息

Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):322-341. doi: 10.1080/15257770.2019.1658115. Epub 2019 Aug 28.

Abstract

The ribose of protein-bound nucleosides and nucleotides displays preferred conformations (usually either North or South), which can be exploited to design enhanced analogs having chemically fixed conformations. We introduce a computational protocol for assembling data from the protein database (PDB) on the ribose and ribose-like conformation of small molecule ligands when complexed with purinergic signaling proteins (including receptors, enzymes and transporters, and related intracellular pathways). Some targets prefer exclusively North (adenosine and P2Y receptors, CD73, adenosine kinase ATP/ADP-binding site, adenosine deaminase), others prefer South (P2Y receptor, E-NTPDase2) or East (adenosine kinase substrates), while others (P2XRs) allow various conformations.

摘要

蛋白质结合的核苷和核苷酸中的核糖呈现出优选的构象(通常为北式或南式),可利用这些构象来设计具有化学固定构象的增强类似物。我们引入了一种计算协议,用于收集蛋白质数据库(PDB)中关于小分子配体与嘌呤能信号蛋白(包括受体、酶和转运蛋白以及相关细胞内途径)复合时的核糖和类核糖构象的数据。一些靶点仅偏好北式构象(腺苷和P2Y受体、CD73、腺苷激酶ATP/ADP结合位点、腺苷脱氨酶),另一些偏好南式构象(P2Y受体、E-NTPDase2)或东式构象(腺苷激酶底物),而其他靶点(P2XRs)则允许多种构象。

相似文献

1
Survey of ribose ring pucker of signaling nucleosides and nucleotides.
Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):322-341. doi: 10.1080/15257770.2019.1658115. Epub 2019 Aug 28.
2
Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors.
Nucleosides Nucleotides Nucleic Acids. 2006;25(12):1425-36. doi: 10.1080/15257770600919027.
5
Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):333-41. doi: 10.1081/NCN-100002305.
7
9
Agonists and antagonists for P2 receptors.
Novartis Found Symp. 2006;276:58-68; discussion 68-72, 107-12, 275-81. doi: 10.1002/9780470032244.ch6.
10
Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Crit Rev Biochem Mol Biol. 2014 Nov-Dec;49(6):473-97. doi: 10.3109/10409238.2014.953627.

引用本文的文献

1
2-Substituted (N)-Methanocarba A Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization.
ACS Pharmacol Transl Sci. 2024 Jun 6;7(7):2154-2173. doi: 10.1021/acsptsci.4c00223. eCollection 2024 Jul 12.
2
Synthesis and Effect of Conformationally Locked Carbocyclic Guanine Nucleotides on Dynamin.
Biomolecules. 2022 Apr 16;12(4):584. doi: 10.3390/biom12040584.
3
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
J Med Chem. 2022 Feb 10;65(3):2409-2433. doi: 10.1021/acs.jmedchem.1c01852. Epub 2022 Jan 26.
4
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.
RSC Med Chem. 2021 Jul 13;12(11):1808-1825. doi: 10.1039/d1md00167a. eCollection 2021 Nov 17.
5
Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.
ChemMedChem. 2020 Nov 4;15(21):1958-1973. doi: 10.1002/cmdc.202000465. Epub 2020 Sep 18.

本文引用的文献

1
Purine Release, Metabolism, and Signaling in the Inflammatory Response.
Annu Rev Immunol. 2019 Apr 26;37:325-347. doi: 10.1146/annurev-immunol-051116-052406. Epub 2019 Jan 24.
2
The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
J Mol Cell Biol. 2019 Jan 1;11(1):1-13. doi: 10.1093/jmcb/mjy052.
3
Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease.
Blood Adv. 2018 Aug 14;2(15):1957-1968. doi: 10.1182/bloodadvances.2018015784.
4
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
J Bioenerg Biomembr. 2018 Jun;50(3):155-173. doi: 10.1007/s10863-018-9751-2. Epub 2018 Mar 29.
5
cAMP: From Long-Range Second Messenger to Nanodomain Signalling.
Trends Pharmacol Sci. 2018 Feb;39(2):209-222. doi: 10.1016/j.tips.2017.11.006. Epub 2017 Dec 27.
6
Purinergic Signalling: Therapeutic Developments.
Front Pharmacol. 2017 Sep 25;8:661. doi: 10.3389/fphar.2017.00661. eCollection 2017.
7
Polypharmacology of conformationally locked methanocarba nucleosides.
Drug Discov Today. 2017 Dec;22(12):1782-1791. doi: 10.1016/j.drudis.2017.07.013. Epub 2017 Aug 3.
8
South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.
J Med Chem. 2016 Jul 28;59(14):6860-77. doi: 10.1021/acs.jmedchem.6b00689. Epub 2016 Jul 13.
9
NAD⁺ in aging, metabolism, and neurodegeneration.
Science. 2015 Dec 4;350(6265):1208-13. doi: 10.1126/science.aac4854.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验